Your browser doesn't support javascript.
loading
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Momont, Corey; Dang, Ha V; Zatta, Fabrizia; Hauser, Kevin; Wang, Caihong; di Iulio, Julia; Minola, Andrea; Czudnochowski, Nadine; De Marco, Anna; Branch, Kaitlin; Donermeyer, David; Vyas, Siddhant; Chen, Alex; Ferri, Elena; Guarino, Barbara; Powell, Abigail E; Spreafico, Roberto; Yim, Samantha S; Balce, Dale R; Bartha, Istvan; Meury, Marcel; Croll, Tristan I; Belnap, David M; Schmid, Michael A; Schaiff, William Timothy; Miller, Jessica L; Cameroni, Elisabetta; Telenti, Amalio; Virgin, Herbert W; Rosen, Laura E; Purcell, Lisa A; Lanzavecchia, Antonio; Snell, Gyorgy; Corti, Davide; Pizzuto, Matteo Samuele.
Affiliation
  • Momont C; Vir Biotechnology, San Francisco, CA, USA.
  • Dang HV; Vir Biotechnology, San Francisco, CA, USA.
  • Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Hauser K; Vir Biotechnology, San Francisco, CA, USA.
  • Wang C; Vir Biotechnology, St. Louis, MO, USA.
  • di Iulio J; Vir Biotechnology, San Francisco, CA, USA.
  • Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA.
  • De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Branch K; Vir Biotechnology, San Francisco, CA, USA.
  • Donermeyer D; Vir Biotechnology, St. Louis, MO, USA.
  • Vyas S; Vir Biotechnology, San Francisco, CA, USA.
  • Chen A; Vir Biotechnology, San Francisco, CA, USA.
  • Ferri E; Vir Biotechnology, San Francisco, CA, USA.
  • Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Powell AE; Vir Biotechnology, San Francisco, CA, USA.
  • Spreafico R; Vir Biotechnology, San Francisco, CA, USA.
  • Yim SS; Vir Biotechnology, San Francisco, CA, USA.
  • Balce DR; Vir Biotechnology, San Francisco, CA, USA.
  • Bartha I; Vir Biotechnology, San Francisco, CA, USA.
  • Meury M; Vir Biotechnology, San Francisco, CA, USA.
  • Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK.
  • Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.
  • Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Schaiff WT; Vir Biotechnology, St. Louis, MO, USA.
  • Miller JL; Vir Biotechnology, San Francisco, CA, USA.
  • Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Telenti A; Vir Biotechnology, San Francisco, CA, USA.
  • Virgin HW; Vir Biotechnology, San Francisco, CA, USA.
  • Rosen LE; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Purcell LA; Vir Biotechnology, San Francisco, CA, USA.
  • Lanzavecchia A; Vir Biotechnology, San Francisco, CA, USA.
  • Snell G; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Corti D; Vir Biotechnology, San Francisco, CA, USA. gsnell@vir.bio.
  • Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.
Nature ; 619(7970): E50, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37407829
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nature Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nature Year: 2023 Type: Article Affiliation country: United States